Trump says the policy is aimed at bringing generic pharmaceutical production back to the United States, with penalties for companies that choose not to establish manufacturing plants in the US

US Secretary of State Marco Rubio anticipates Indian concern over new generic drug import tariffs. These tariffs will rise significantly after August 1, 2026, impacting imports. …

There will be no levies for two years, after which the tariff rate will be raised to 100% for one year and to 200% thereafter, said Donald Trump.